Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.38
GB's Cash to Debt is ranked lower than
78% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. GB: 0.38 )
Ranked among companies with meaningful Cash to Debt only.
GB' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.21 Max: N/A
Current: 0.38
Equity to Asset 0.66
GB's Equity to Asset is ranked higher than
53% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. GB: 0.66 )
Ranked among companies with meaningful Equity to Asset only.
GB' s Equity to Asset Range Over the Past 10 Years
Min: 0.28  Med: 0.54 Max: 0.75
Current: 0.66
0.28
0.75
Interest Coverage 6.24
GB's Interest Coverage is ranked lower than
77% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. GB: 6.24 )
Ranked among companies with meaningful Interest Coverage only.
GB' s Interest Coverage Range Over the Past 10 Years
Min: 0.05  Med: 3.65 Max: 17.79
Current: 6.24
0.05
17.79
F-Score: 5
Z-Score: 3.33
M-Score: -2.76
WACC vs ROIC
8.65%
4.90%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.29
GB's Operating margin (%) is ranked higher than
61% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. GB: 6.29 )
Ranked among companies with meaningful Operating margin (%) only.
GB' s Operating margin (%) Range Over the Past 10 Years
Min: 0.2  Med: 7.63 Max: 12.93
Current: 6.29
0.2
12.93
Net-margin (%) 4.83
GB's Net-margin (%) is ranked higher than
61% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. GB: 4.83 )
Ranked among companies with meaningful Net-margin (%) only.
GB' s Net-margin (%) Range Over the Past 10 Years
Min: -1.72  Med: 5.09 Max: 8.06
Current: 4.83
-1.72
8.06
ROE (%) 5.04
GB's ROE (%) is ranked higher than
57% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. GB: 5.04 )
Ranked among companies with meaningful ROE (%) only.
GB' s ROE (%) Range Over the Past 10 Years
Min: -2.39  Med: 5.26 Max: 9.6
Current: 5.04
-2.39
9.6
ROA (%) 3.29
GB's ROA (%) is ranked higher than
62% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. GB: 3.29 )
Ranked among companies with meaningful ROA (%) only.
GB' s ROA (%) Range Over the Past 10 Years
Min: -1.07  Med: 2.76 Max: 6.01
Current: 3.29
-1.07
6.01
ROC (Joel Greenblatt) (%) 14.20
GB's ROC (Joel Greenblatt) (%) is ranked higher than
63% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. GB: 14.20 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
GB' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 0.69  Med: 19.71 Max: 25.97
Current: 14.2
0.69
25.97
Revenue Growth (3Y)(%) 3.20
GB's Revenue Growth (3Y)(%) is ranked lower than
51% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. GB: 3.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
GB' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0.2  Med: 11.00 Max: 30.3
Current: 3.2
0.2
30.3
EBITDA Growth (3Y)(%) 1.90
GB's EBITDA Growth (3Y)(%) is ranked lower than
52% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. GB: 1.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
GB' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.6  Med: 5.90 Max: 30.6
Current: 1.9
-7.6
30.6
EPS Growth (3Y)(%) 15.10
GB's EPS Growth (3Y)(%) is ranked higher than
66% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. GB: 15.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
GB' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -19.8  Med: 9.20 Max: 146.6
Current: 15.1
-19.8
146.6
» GB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

GB Guru Trades in Q1 2015

Jim Simons Sold Out
Paul Tudor Jones Sold Out
Ken Fisher 612,832 sh (-0.57%)
Diamond Hill Capital 389,540 sh (-5.60%)
Mario Gabelli 163,000 sh (-6.11%)
Joel Greenblatt 241,538 sh (-18.58%)
Chuck Royce 34,001 sh (-20.00%)
» More
Q2 2015

GB Guru Trades in Q2 2015

Steven Cohen 165,800 sh (New)
Paul Tudor Jones 4,416 sh (New)
Ken Fisher 736,437 sh (+20.17%)
Chuck Royce Sold Out
Diamond Hill Capital 387,815 sh (-0.44%)
Mario Gabelli 137,200 sh (-15.83%)
Joel Greenblatt 43,533 sh (-81.98%)
» More
Q3 2015

GB Guru Trades in Q3 2015

Jim Simons 28,900 sh (New)
Paul Tudor Jones 6,787 sh (+53.69%)
Diamond Hill Capital 389,581 sh (+0.46%)
Steven Cohen Sold Out
Ken Fisher 701,373 sh (-4.76%)
Joel Greenblatt 34,282 sh (-21.25%)
Mario Gabelli 107,900 sh (-21.36%)
» More
Q4 2015

GB Guru Trades in Q4 2015

Jim Simons Sold Out
Ken Fisher 697,094 sh (-0.61%)
Mario Gabelli 91,200 sh (-15.48%)
Diamond Hill Capital 327,051 sh (-16.05%)
» More
» Details

Insider Trades

Latest Guru Trades with GB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 28.30
GB's P/E(ttm) is ranked higher than
50% of the 260 Companies
in the Global Medical Devices industry.

( Industry Median: 28.39 vs. GB: 28.30 )
Ranked among companies with meaningful P/E(ttm) only.
GB' s P/E(ttm) Range Over the Past 10 Years
Min: 11.04  Med: 32.49 Max: 534
Current: 28.3
11.04
534
Forward P/E 9.61
GB's Forward P/E is ranked higher than
93% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 18.42 vs. GB: 9.61 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 28.30
GB's PE(NRI) is ranked lower than
54% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 27.40 vs. GB: 28.30 )
Ranked among companies with meaningful PE(NRI) only.
GB' s PE(NRI) Range Over the Past 10 Years
Min: 11.04  Med: 31.72 Max: 623
Current: 28.3
11.04
623
P/B 1.35
GB's P/B is ranked higher than
74% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. GB: 1.35 )
Ranked among companies with meaningful P/B only.
GB' s P/B Range Over the Past 10 Years
Min: 0.97  Med: 1.55 Max: 2.46
Current: 1.35
0.97
2.46
P/S 1.37
GB's P/S is ranked higher than
69% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. GB: 1.37 )
Ranked among companies with meaningful P/S only.
GB' s P/S Range Over the Past 10 Years
Min: 0.77  Med: 1.33 Max: 2.97
Current: 1.37
0.77
2.97
PFCF 50.00
GB's PFCF is ranked lower than
67% of the 205 Companies
in the Global Medical Devices industry.

( Industry Median: 34.47 vs. GB: 50.00 )
Ranked among companies with meaningful PFCF only.
GB' s PFCF Range Over the Past 10 Years
Min: 6.12  Med: 26.26 Max: 169.91
Current: 50
6.12
169.91
POCF 15.45
GB's POCF is ranked higher than
76% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 19.47 vs. GB: 15.45 )
Ranked among companies with meaningful POCF only.
GB' s POCF Range Over the Past 10 Years
Min: 5.14  Med: 11.46 Max: 28.04
Current: 15.45
5.14
28.04
EV-to-EBIT 25.27
GB's EV-to-EBIT is ranked higher than
50% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. GB: 25.27 )
Ranked among companies with meaningful EV-to-EBIT only.
GB' s EV-to-EBIT Range Over the Past 10 Years
Min: 8  Med: 22.50 Max: 819.4
Current: 25.27
8
819.4
EV-to-EBITDA 14.34
GB's EV-to-EBITDA is ranked higher than
66% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 16.11 vs. GB: 14.34 )
Ranked among companies with meaningful EV-to-EBITDA only.
GB' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.8  Med: 12.50 Max: 20.7
Current: 14.34
5.8
20.7
PEG 3.14
GB's PEG is ranked lower than
51% of the 68 Companies
in the Global Medical Devices industry.

( Industry Median: 3.39 vs. GB: 3.14 )
Ranked among companies with meaningful PEG only.
GB' s PEG Range Over the Past 10 Years
Min: 0.7  Med: 5.64 Max: 680.28
Current: 3.14
0.7
680.28
Shiller P/E 37.20
GB's Shiller P/E is ranked lower than
57% of the 72 Companies
in the Global Medical Devices industry.

( Industry Median: 31.42 vs. GB: 37.20 )
Ranked among companies with meaningful Shiller P/E only.
GB' s Shiller P/E Range Over the Past 10 Years
Min: 24.15  Med: 40.84 Max: 69.31
Current: 37.2
24.15
69.31
Current Ratio 3.10
GB's Current Ratio is ranked higher than
56% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. GB: 3.10 )
Ranked among companies with meaningful Current Ratio only.
GB' s Current Ratio Range Over the Past 10 Years
Min: 1.6  Med: 3.23 Max: 8.42
Current: 3.1
1.6
8.42
Quick Ratio 1.70
GB's Quick Ratio is ranked lower than
56% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. GB: 1.70 )
Ranked among companies with meaningful Quick Ratio only.
GB' s Quick Ratio Range Over the Past 10 Years
Min: 0.79  Med: 1.88 Max: 6.93
Current: 1.7
0.79
6.93
Days Inventory 117.96
GB's Days Inventory is ranked higher than
59% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. GB: 117.96 )
Ranked among companies with meaningful Days Inventory only.
GB' s Days Inventory Range Over the Past 10 Years
Min: 86  Med: 99.15 Max: 116.63
Current: 117.96
86
116.63
Days Sales Outstanding 60.56
GB's Days Sales Outstanding is ranked higher than
63% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. GB: 60.56 )
Ranked among companies with meaningful Days Sales Outstanding only.
GB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.11  Med: 60.08 Max: 68.3
Current: 60.56
42.11
68.3
Days Payable 47.40
GB's Days Payable is ranked lower than
61% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. GB: 47.40 )
Ranked among companies with meaningful Days Payable only.
GB' s Days Payable Range Over the Past 10 Years
Min: 27.39  Med: 37.16 Max: 60.2
Current: 47.4
27.39
60.2

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 32.69
GB's Price/Net Current Asset Value is ranked lower than
89% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 8.50 vs. GB: 32.69 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
GB' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 44.56  Med: 75.17 Max: 3610
Current: 32.69
44.56
3610
Price/Tangible Book 3.94
GB's Price/Tangible Book is ranked higher than
52% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 4.04 vs. GB: 3.94 )
Ranked among companies with meaningful Price/Tangible Book only.
GB' s Price/Tangible Book Range Over the Past 10 Years
Min: 5.43  Med: 11.77 Max: 74.81
Current: 3.94
5.43
74.81
Price/Projected FCF 0.96
GB's Price/Projected FCF is ranked higher than
85% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. GB: 0.96 )
Ranked among companies with meaningful Price/Projected FCF only.
GB' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.52  Med: 0.94 Max: 2.49
Current: 0.96
0.52
2.49
Price/DCF (Earnings Based) 2.65
GB's Price/DCF (Earnings Based) is ranked lower than
65% of the 43 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 2.65 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.03
GB's Price/Median PS Value is ranked lower than
52% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. GB: 1.03 )
Ranked among companies with meaningful Price/Median PS Value only.
GB' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.6  Med: 1.53 Max: 3.99
Current: 1.03
0.6
3.99
Price/Graham Number 2.23
GB's Price/Graham Number is ranked higher than
59% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. GB: 2.23 )
Ranked among companies with meaningful Price/Graham Number only.
GB' s Price/Graham Number Range Over the Past 10 Years
Min: 1.98  Med: 4.35 Max: 24.16
Current: 2.23
1.98
24.16
Earnings Yield (Greenblatt) (%) 4.00
GB's Earnings Yield (Greenblatt) (%) is ranked higher than
71% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. GB: 4.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
GB' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.1  Med: 4.45 Max: 12.5
Current: 4
0.1
12.5
Forward Rate of Return (Yacktman) (%) 3.15
GB's Forward Rate of Return (Yacktman) (%) is ranked lower than
56% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. GB: 3.15 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
GB' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 0.8  Med: 11.20 Max: 25.1
Current: 3.15
0.8
25.1

More Statistics

Revenue(Mil) $653
EPS $ 1.20
Beta1.11
Short Percentage of Float3.40%
52-Week Range $33.35 - 63.19
Shares Outstanding(Mil)30.56

Analyst Estimate

Dec15 Dec16
Revenue(Mil)
EPS($) 2.75 3.54
EPS without NRI($) 2.75 3.54

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WGB.Germany,
Greatbatch Inc is a Delaware corporation was incorporated on July 11, 1997. The Company designs and manufactures critical components that help to advance medical device technology across various applications. The Company operates in two segments namely Greatbatch Medical and QiG Group. Greatbatch Medical designs and manufactures products where Greatbatch either owns the intellectual property or has unique manufacturing and assembly expertise. Its products include medical devices and components for the cardiac, neuromodulation, orthopaedics, portable medical, vascular and energy markets among others. The Greatbatch Medical segment also offers value-added assembly and design engineering services for medical devices that utilize its component products.. QiG segment develops medical device systems for some of healthcare's challenges and reflects Greatbatch's strategic evolution of its product offerings. Through the research and development professionals in QiG, the Company is now investing in three areas namely new medical device systems commercialization, collaborative programs with OEM customers, and strategic equity positions in start-up companies to grow a diversified and distinctive portfolio. The medical device systems developed by QiG are manufactured by Greatbatch Medical. The Company's customers include large multi-national original equipment manufacturers. The Company is subject to direct governmental regulation including the laws and regulations generally applicable to all businesses in the jurisdictions in which it operates.
» More Articles for GB

Headlines

Articles On GuruFocus.com
BlackBerry Seems To Be Making The Right Moves Mar 08 2014 
Diamond Hill Capital Buys EOG, BR, GB, TEVA, BGS, IWD, HCC Jan 20 2011 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 09 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 10 2010 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 10 2009 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 11 2009 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2009 

More From Other Websites
Aleva Neurotherapeutics and Greatbatch Collaborate on Next-Generation Device for Deep Brain... Feb 01 2016
Aleva Neurotherapeutics and Greatbatch Collaborate on Next-Generation Device for Deep Brain... Feb 01 2016
Greatbatch awarded $37.5M in patent infringement lawsuit Jan 28 2016
Greatbatch (GB) Wins Patent Suit, Gets $35.7M in Damages Jan 27 2016
Greatbatch Awarded $37.5 Million in Patent Infringement Lawsuit Against AVX Corporation Jan 26 2016
Greatbatch Awarded $37.5 Million in Patent Infringement Lawsuit Against AVX Corporation Jan 26 2016
The Zacks Analyst Blog Highlights: Intel, NVIDIA, Greatbatch, M/A-Com Technology Solutions Holdings... Jan 20 2016
Forget Intel: Buy These Semiconductor Stocks Instead Jan 19 2016
Greatbatch Unveils 2015 Preliminary Results & 2016 Outlook Jan 12 2016
Can Greatbatch (GB) Stock Continue to Grow Earnings? Jan 12 2016
Greatbatch, Inc. Provides Preliminary 2015 Revenue Results and 2016 Guidance Jan 11 2016
Greatbatch, Inc. Provides Preliminary 2015 Revenue Results and 2016 Guidance Jan 11 2016
GREATBATCH, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial... Jan 11 2016
Greatbatch, Inc. breached its 50 day moving average in a Bearish Manner : December 21, 2015 Dec 21 2015
GREATBATCH, INC. Financials Dec 08 2015
Greatbatch, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 07 2015
What Do Hedge Funds Think of Greatbatch Inc (GB)? Dec 02 2015
Chemours and Greatbatch are big market movers Dec 01 2015
Chemours and Greatbatch are big market movers Dec 01 2015
Greatbatch Receives FDA Approval for Algovita SCS System Dec 01 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK